1. Actinium Pharmaceuticals, Inc. (ATNM)
Historical Data
ì½{{Û6²8ü÷o?ë<íÚçH4ïyÝçÖd7I³IÚn¾~(hS¢LR²¯¿û;¸IPd9íö¸D$07ÌÀß¾ b?[Í4ɦѷùþK¼Ùøô Íú?~<² ¢Ó(O²)ð2¯ïÇQôS¿òż4==PzÅsiâþ8Ah&AýÅ<õ½I#/Ro¾ýÿüm¼þ$Sy?ñe§lÔwêgnu¢ëyàãYfPü:²Éi¡úä¡' ³0½¨OZ?U[Å^6> °õ'qÊÆßä7cÙ§¿ü¿ÿ÷·(]JNdùþD ,=>÷æóãp:]dÞ0Bù[M~æ½úéý¹1ý4=¤Ù*Bé¡`o ò,HeýÃÛ7mú¿{ú (ùù{ÏO>êÞà¾ÒòçÞjÎõ§_öõ5J6ßûËs½ÜÔçh¸ËOþû·{ûteÐÝç«÷/ÝÌKP_Ï@õÍ/y ¬5åçótnÿôy$I¼MAR~¸~¯ý½A~Oç^¦ñì{o1Fϼ$¾úáæõçûõ9úû+3¼ ÷õ¥&?yÑuz¥¼¦¯ö¨óÞÌGÁ3,3¢S§îpø)ü~úJøO´©üÌúùs ½5ðÍÉÈÉõiôaõF}µ¿Iñ9LûñX~þl©¾z¶¿fê¡»só2AótºÛÏ@þãfÝ?¿y¹zoõ÷ MêÏnæÈÿÑýqà/aê9íML¼ßüÓ½?ø-ÒOÐóåûîý^¥?}Î ë±óîÓâǧûT/RÉÏ";ú´üt±wÈÔHå§7Sûíënö8ÕÍ_ÅQÎÆ ü7þ/W/ýÉ'xï½ æùÙßß0>ükýýK åÊû1ûü¿ßïïQ2)Ö»?,QB&S3S&Ê?ÜáÞùç4Ào/2ùü§½|ú£¹?¤/&?óýÕÕ³=ÉçáËÎÓ |¬dÜ"ÁßnAò3múÚùùù|oÐSÕð³ü\ë=ýðËÙþ% ¿ÂÓr æýÃÿÅþ¢azÉ;ËW£0yÿ!Ü®e¼|X½\~ÿ~º¿nÓ©í¹ú,{m¼ôö+0q0"½¿H_ýk-ý)Ì0\¼è[ÿ¡½Á~ç-òó¾¢_üíYà 3L³Ðþ¾xû¯±¿¿yçÁLýüÓYÿóbFÀ (øÅIÀÞü0þåguñÏýn³¡~G|óZùùã?î8Y½E0¯-QN0þøñýù»ï÷çÓÉ°*^£O?OÔó½[ýg3/Z¥!ðOj¿úÙ³öÇø?{àå§Wgÿ|ª>ßýS ø}äðdôï½{uÖ¦gþa©þöÌâY¸JïÁ#² ñ¢´'½ù²txöéÝÛ# ë_JDÇô¤wè>)¾ñ¦óéHP^êK¿à¡ô2aáoÇ´¿}ÕïK¯^=?OX¼¤ÑåEtþñÓÙOR¿Ï |zûæüÓÙ÷ÜëÔOÂy&áøìéAn²ãoéÑ·R,«¨¦ÉÁ·çç?~øçóçgÎÎÏ¥Séïx'Ïq õðàöîàèäoÇ´bµï¯ëÁ?A=áá¨(%ÇqþB¾FÃâãvÐ+F{ì¦_ÇOGÛÏ4ÃVh?#¼|ûëíÁhE/nü7£wÞÞyià]}ÿñ w®¦Ã8wggïßÀóxý0}DÙÛ0ÑD~<ÒA_5ÿÓ;ÀAï¸vPF¾{ /"/yë%(ûâ6nïú` Úª£ª®k[½Ñ4:ª:е³·ÒçîjUNõè£YVÀ°dMw-ÃÌ!À³ñ5®{E&À ¼|ñÏ_úúqô
2. ATNM Interactive Stock Chart | Actinium Pharmaceuticals, Inc. Stock
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
3. ATNM May 2024 12.500 call (ATNM240517C00012500)
Find the latest ATNM May 2024 12.500 call (ATNM240517C00012500) stock quote, history, news and other vital information to help you with your stock trading ...
Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.
4. How Actinium Pharmaceuticals (ATNM) Stock Stands Out in a ...
Jun 12, 2020 · In this article: ATNM. One stock that might be an intriguing choice for investors right now is Actinium Pharmaceuticals, Inc. ATNM.
Actinium Pharmaceuticals (ATNM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
5. ATNM Apr 2024 5.000 put - Yahoo Finance
(NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that results from the Phase 3 SIERRA ...
Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.
6. ATNM interactive stock chart | Actinium Pharmaceuticals, Inc. stock
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage ...
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.
7. Actinium Pharmaceuticals Inc (ATNM) Stock Price & News - Google Finance
Get the latest Actinium Pharmaceuticals Inc (ATNM) real-time quote, historical ... Yahoo Finance. 17 minutes ago. Stock market today: Dow jumps, Nvidia's ...
See AlsoJackie Kay Poems - Poem AnalysisGet the latest Actinium Pharmaceuticals Inc (ATNM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
8. Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical ...
Jun 17, 2020 · Is (ATNM) Outperforming Other Medical Stocks This Year ... Yahoo Finance• 16h ago. Stocks are about to hit a 'wall of money ...
Is (ATNM) Outperforming Other Medical Stocks This Year?
9. Actinium Pharmaceuticals (ATNM) Jumps: Stock Rises 6.7%
Jun 9, 2020 · Actinium Pharmaceuticals (ATNM) Jumps: Stock Rises 6.7%. Zacks ... Yahoo Finance• 3h ago. Toyota Subsidiary to Close its Largest U.S. ...
Actinium Pharmaceuticals (ATNM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
10. ATNM Jul 2024 10.000 call - Yahoo Finance
Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year. Zacks•yesterday.
Find the latest ATNM240719C00010000 (ATNM240719C00010000) stock quote, history, news and other vital information to help you with your stock trading and investing.
11. Actinium Pharmaceuticals, Inc. (ATNM) Stock - Kavout
... (Yahoo Finance). 2023-08-14 21:41. Actinium: Q2 Earnings Snapshot (Yahoo Finance). 2023-07-23 19:00. Actinium Pharma to Present at the 2nd Annual Targeted ...
Explore the latest news, in-depth analysis, performance evaluation, and Q&A for Actinium Pharmaceuticals, Inc. (ATNM) stock. Gain valuable insights from earnings call transcripts, filings, and AI-driven sentiment analysis. Access comprehensive stock chart, news updates, technical and fundamental analysis to empower your trading and investment decisions.
12. NYSEMKT: ATNM Actinium Pharmaceuticals Inc Stock
's (NYSEMKT:ATNM)? · Yahoo Finance UK•a month ago. Actinium Pharmaceuticals (NYSEMKT:ATNM) Is In A Good Position To Deliver On Growth Plans · Yahoo Style•a ...
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies. Its lead product candidate is Iomab-B, which is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug candidate that is in a Phase II trial for patients newly diagnosed with AML age 60 and over; and Actimab-M, a drug candidate, for the treatment of patients with penta refractory multiple myeloma in a Phase 1 clinical trial. Its Antibody Warhead Enabling technology platform is currently being utilized in a research collaboration with Astellas Pharma, Inc. The company was founded in 2000 and is based in New York, New York.
